SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
gentledragon
Lv1
65 积分
2021-09-28 加入
最近求助
最近应助
互助留言
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
2天前
已完结
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
16天前
已完结
Pyroptosis, metabolism, and tumor immune microenvironment
1个月前
已完结
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
1个月前
已完结
Myostatin: Basic biology to clinical application
1个月前
已完结
Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF‐κB‐independent, FoxO1‐dependent mechanism
1个月前
已完结
Myostatin/activin pathway antagonism: Molecular basis and therapeutic potential
1个月前
已完结
A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia
1个月前
已完结
Hepatocyte‐derived MASP1‐enriched small extracellular vesicles activate HSCs to promote liver fibrosis
1个月前
已完结
Evolving therapeutic landscape of advanced hepatocellular carcinoma
1个月前
已完结
没有进行任何应助
感谢
1个月前
时间长了【积分已退回】
1年前
已获得【积分已退回】
1年前
10.1021/acs.analchem.1c04038
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论